|
| News Updates |
 |
IAVI announces first vaccinations in IAVI G004, a Phase 1 clinical trial of a promising HIV vaccine approach
iavi | January 6, 2026
|
 |
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1
Science | December 19, 2025
|
 |
How HIV Capsid Research Sparked a New Era in Prevention
American Society for Microbiology | December 18, 2025
|
 |
Researchers Identify Why Some People With HIV Achieve Remission After Antibody Treatment
Mass General Brigham | December 1, 2025
|
 |
New Trials Hint That ‘Functional Cure’ for HIV May Be Within Reach, Helping Some Patients Achieve Lasting Remission
Smithsonian | December 1, 2025
|
 |
‘Is this my last pill ever?’ UCSF therapy offers patients a hint at a cure for HIV
UC SF | December 1, 2025
|
 |
Long-Term HIV Control: Could this Combination Therapy Be the Key?
UC SF | December 1, 2025
|
 |
Subgingival Bacterial Microbiota Profile of People Living With HIV-1 Under HAART: A Systematic Review
Spec Care Dentist. 2025 Nov-Dec;45(6):e70121. doi: 10.1111/scd.70121.
|
 |
Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency
Nature | November 24, 2025
|
 |
New AI investment aims to accelerate the search for an effective HIV vaccine
News Medical | November 18, 2025
|
 |
Artificial intelligence in HIV research, policy, and clinical care
The Lancet | October 29, 2025
|
 |
How HIV research drives health innovation in multiple diseases
Nature Medicine | October 24, 2025
|
 |
amfAR Awards New HIV Cure-Focused Research Grants Totaling $2.4 Million
amfAR | October 16, 2025
|
 |
Gilead Presents New HIV Research Data at EACS 2025 – Driving Scientific Innovation in Treatment and Prevention
Gilead | October 15, 2025
|
 |
EACS 2025: Investigational HIV bNAb N6LS shown safe, tolerable in Phase 2b trial
European AIDS Treatment Group | October 18, 2025
|
 |
Simultaneous priming of HIV broadly neutralizing antibody precursors to multiple epitopes by germline-targeting mRNA-LNP immunogens...
Science | October 17, 2025
|
 |
amfAR Awards $2.4 Million in New HIV Cure-Focused Research Grants
amfAR, The Foundation for AIDS Research | October 16, 2025
|
 |
German researchers find highly effective HIV antibody
DW | October 15, 2025
|
 |
Will HIV Soon Be Curable? New Therapies Offer Hope
Medscape | October 15, 2025
|
 |
Vitamin A transporter reactivates latent HIV, providing another step towards a cure
EATG | October 9, 2025
|
 |
Lifesaving new antibody blocks 98.5% of all known HIV strains
Yahoo | October 7, 2025
|
 |
Researchers discover how HIV hides in different parts of the body
News-medical | October 6, 2025
|
 |
Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia
Nature | October 3, 2025
|
 |
Determining the Feasibility of a Mail-In Saliva Sample Protocol for Persons Living with HIV in Two Urban Northeast United States Clinics
NIH | October 2, 2025
|
 |
Cabotegravir PrEP implant might prevent HIV for a year
European AIDS Treatment Group | September 30, 2025
|
 |
Stem Cells May Hold Key to HIV Cure
Medscape | September 25, 2025
|
 |
A research framework to support re-engagement and continuous engagement in HIV care
The Lancet | September 24, 2025
|
 |
After NIH ends landmark HIV research program, Duke has 9 months to plan next steps
The Chronicle | September 23, 2025
|
 |
OHSU awarded $6.7 million to study effects of cannabis use during pregnancy in people with HIV
EATG | September 22, 2025
|
 |
NIH Grant Aims for Childhood Vaccine Against HIV
Weill Cornell | September 18, 2025
|
 |
A handful of patients have been cured of HIV. OHSU just won $8.4 million to decode their cells for a cure
OPB | August 29, 2025
|
 |
Comorbidities in HIV: Big data study reveals molecular links
EATG | August 24, 2025
|
 |
Bolstering HIV Cure Research in the Current Political Context: A Statement from The Well Project and the Women's Research Initiative on HIV/AIDS
The Well Project | August 21, 2025
|
 |
Genetic and molecular landscape of comorbidities in people living with HIV
Nature | August 20, 2025
|
 |
Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis
Nature | August 20, 2025
|
 |
A randomized clinical trial testing the effectiveness of an adapted online HIV/AIDS prevention intervention among Latino men
Scientific Reports | August 7, 2025
|
| |
|
|